|Reliable and detailed biological, chemical, and pharmacological information
Collated and curated by our team of scientists, Integrity empowers your research with data from your perspective.
|High quality biological systems content in context
Essential systems biology information on genes, proteins, molecular processes, interactions, networks and more, in a powerful analytical tool.
|System-level reconstructions of disease biology
Pathology pathways, biomarkers, drugs, OMICs experiments, and more. The Modules were developed through the industry-academy MetaMiner Partnership program.
|Industry-Academia collaborations to enhance disease understanding
Your expert knowledge and ideas; our highly specialized expertise in manual curation and disease map development working together to create new pathways quickly.
|A leading systems pharmacology solution
Extensive manually curated information on biological effects of small molecule compounds.
|Manually curated systems biology intelligence
Functional pathway analysis solutions and services for a wide range of applications in life science research and drug development.
|The daily biopharmaceutical news source
BioWorld™ Today delivers actionable intelligence on the biotech science that drives the business, which funds the means to heal disease. With writers and editors stationed around the globe, BioWorld™ Today reports the breaking news — and provides key perspective — on hundreds of medicines in development, the companies behind those therapeutic candidates, the business development transactions that evolve the market and the regulatory hurdles that both challenge and guard the process.
|One source for comprehensive competitive analysis
Pipeline intelligence, drugs, conferences, deals, patents, companies — updated frequently and all in one place for fast answers to critical questions.
|Potential Partnering Opportunities: Bide your time with confidence
While you're focusing on drug development partnerships with immediate promise, Cortellis Opportunity Monitor watches candidates with potential down the line. When significant changes occur, we'll let you know — so you can quickly determine if it's time to act.
|The most efficient way to look at the world's epidemiology data
The Incidence and Prevalence Database (IPD) is the most efficient way to look at the world's epidemiology data. The IPD covers over 4,500 diseases, procedures, symptoms and other health issues for incidence, prevalence, morbidity, mortality, comorbidity, treated or diagnosed rates, cost and much more.
|The news source of record for the high-tech medical technology industry
Medical Device Daily™ is the news source of record for the high-tech medical technology industry and is relied on by thousands of industry insiders every business morning. This business-focused intelligence service is the flagship publication of BioWorld's med-tech group, the publishers, also, of the annual Medical Device Daily™ State of the Industry Report, and much more. Much like its sister publication BioWorld™ Today, Medical Device Daily offers unbiased business-focused news, written by the best reporters in the industry, to an executive audience striving to stay ahead of the curve in this fast-paced industry.
|Unique strategic intelligence and powerful competitive analysis
API intelligence, patents, routes of synthesis and more — Newport Premium (for Generics) helps you be first to find the drug, first to find the niche, first to make the deal, and first to get to market.
|A good deal – faster. With enhanced content, analytics and visualization tools
Whether you are looking to buy, sell, or license a drug candidate, our gold standard biopharma deals intelligence gives you insight to support your own deals. Thomson Reuters Recap IQ offers you rapid insight into critical deal making trends and allows you to uncover nuances in specific deal types.
|Global clinical trial protocols and outcomes
Accelerate clinical trial development decisions and portfolio strategy via expertly curated clinical trials information skilfully integrated with other scientific and competitive intelligence from Thomson Reuters.
|Current and accurate global regulatory information
Frequently updated with regional and global regulatory guidelines and reports to give you a competitive advantage and minimize regulatory risks.